Intrinsiqq
ZYNEX INC logo

Zynex Inc

ZYXIQ
⊜ Compare
ProfitabilityUnprofitableGrowthModeratingCash FlowCash burnValuationN/A
What stands out

Operating margin is thin at 3.11%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.

What's changing

Revenue grew 4.4%, steady but not accelerating. Margins contracted 2.7pp, which offsets some of the top-line progress.

What deserves caution

Free cash flow declined 27% versus the prior year, cash generation momentum has weakened. ROIC dropped from 7.18% to 4.62%, capital efficiency is deteriorating.

Profitability & Returns

Revenue (TTM)

$108M

▲ +4.4% YoY

Net Income (TTM)

-$74M

▼ -69.2% YoY

Op. Margin

-62.76%

▼ -2.7pp YoY

ROIC

-93.18%

▼ -2.6pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$21M

▼ -26.6% YoY

Op. Cash Flow (TTM)

-$21M

▼ -28.4% YoY

Net Debt

-$1M

Net Cash Position

Cash & Equiv.

$13M

5Y CAGR: +33.4%

5Y CAGR: +14.6%

Continue Research

SourceComputed from the 10-Q filed 11 Nov 2025, covering the period ending 30 Sept 2025, as reported to the SEC. Data last refreshed 6 Jun 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.

Related stocks: Electromedical & Electrotherapeutic Apparatus

Spot a number that looks wrong?

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.